儿童X连锁低磷血症的管理:国际工作组临床实践指南
国际工作组(IWG)制定儿童X连锁低磷血症(XLH)诊断、评估、管理和监测的新指南。50名国际专家在2023—2024年召开18次电话会议,开展两项系统评价比较布罗索尤单抗与传统治疗(磷酸盐和活性维生素D)或无治疗、以及传统治疗与无治疗对患者重要结局的影响,采用GRADE方法评价证据确定性,并结合叙述性综述和专家临床实践调查形成推荐。
要点
- 提出了建立儿童XLH诊断的方法。
- 制定了儿童XLH治疗策略的GRADE分级推荐。
- 监测推荐为弱推荐、证据确定性极低,基于IWG专家临床实践调查。
核心结论
- 该临床实践指南更新了当前关于XLH诊断和管理的证据,并为参与XLH患儿照护的多学科医疗专业人员提供全面指导。
研究设计与样本
- 国际工作组(IWG)由来自加拿大、美国、欧洲、亚洲和南美洲的50名XLH国际专家、方法学专家和一名患者伙伴组成,于2023—2024年召开18次电话会议。
- 开展两项系统评价:比较布罗索尤单抗与传统治疗(磷酸盐和活性维生素D)或无治疗的影响,以及比较传统治疗与无治疗对患者重要结局的影响。
- 采用GRADE方法评价证据确定性,并完成关于XLH诊断和基因检测作用的叙述性综述,以及为监测推荐提供依据的专家临床实践调查。
主要发现
- 提出了建立儿童XLH诊断的方法。
- 制定了儿童XLH治疗策略的GRADE分级推荐。
- 监测推荐为弱推荐、证据确定性极低,基于IWG专家的临床实践调查。
- 指南还涉及牙齿并发症并提出可能的减轻策略。
关键数值与推荐
- 监测推荐为弱推荐、证据确定性极低,基于IWG专家的临床实践调查。
临床怎么用
- 原文未据此给出推荐。
局限性
- 监测推荐为弱推荐、证据确定性极低,基于IWG专家的临床实践调查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: An International Working Group (IWG) developed new guidelines on the diagnosis, evaluation, management, and monitoring of X-linked hypophosphatemia (XLH) in children. Over the past 5 years, important advances have occurred in our understanding of the presentation, complications, and treatment of XLH. METHODS: A group of 50 international experts in XLH from Canada, the United States, Europe, Asia, and South America, along with methodology experts and a patient partner, held 18 teleconference meetings in 2023-2024. These meetings addressed key issues regarding diagnosing, evaluating, managing, and monitoring XLH in children. Two systematic reviews were conducted to examine the impact of burosumab compared to conventional therapy (phosphate salts and active vitamin D) or no therapy, and to assess the impact of conventional therapy vs no therapy on patient-important outcomes. The certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Additionally, narrative reviews were completed on XLH diagnosis and the role of genetic testing, and an expert clinical practice survey informed the monitoring recommendations. OUTCOMES: An approach to establishing the diagnosis of XLH is presented. GRADEd recommendations were developed on treatment strategies for XLH in children. Monitoring recommendations, GRADEd as weak with very low certainty, were based on clinical practice survey of the IWG experts. The guidelines also addressed dental complications and proposed potential strategies to mitigate them. CONCLUSION: These clinical practice guidelines provide an update of the current evidence on the diagnosis and management of XLH and provide a comprehensive guidance for multidisciplinary healthcare professionals involved in the care of children with XLH.
引用
- Ali DS, Carpenter TO, Imel EA, et al. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025. PMID: 39960858. doi:10.1210/clinem/dgaf093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。